Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2026 is -30.87% vs 30.53% in Jun 2026
Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is -9.43% vs 100.00% in Jun 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2026 is -3.94% vs 106.67% in Jun 2026
Interest
QoQ Growth in quarter ended Sep 2026 is -100.00% vs 0.00% in Jun 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
Compare Quarterly Results Of Kabra Drugs With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is -30.87% vs 30.53% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 61.69% vs 0.00% in Sep 2025
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Sep 2026 is -9.43% vs 100.00% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 4.35% vs 560.00% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is -3.94% vs 106.67% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 32.02% vs 607.50% in Sep 2025
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025